Assessing the clinical significance of anti-Cra and anti-M in a chronically transfused sickle cell patient

Leatherbarro, M.B.; Ellisor, S.S.; Collins, P.A.; Douglas, D.K.; Eckrich, R.J.; Esty, S.S.; Baldwin, M.L.; Ness, P.M.

doi:10.21307/immunohematology-2019-1108

References

1. Beattie K. American Red Cross Blood Services, Southeastern Michigan Region, Detroit, MI (personal communication).
Search in Google Scholar Back to article
2. Widmann FK, ed. Technical manual. 9th ed. Arlington, VA: American Association of Blood Banks, 1985:156.
Search in Google Scholar Back to article
3. Ibid, 195–262.
Search in Google Scholar Back to article
4. Garratty G. Predicting the clinical significance of alloantibodies and determining the in vivo survival of transfused red cells. In: Judd WJ, Barnes A, eds. Clinical and serological aspects of transfusion reactions. Arlington, VA: American Association of Blood Banks, 1982:91–119.
Search in Google Scholar Back to article
5. Daniels GL. Blood group antigens of high frequency: a serological and genetical study (thesis). London: MRC Blood Group Unit, University College, 1980:253–65.
Search in Google Scholar Back to article
6. McSwain B, Robins C. A clinically significant anti-Cr^a (letter). Transfusion 1988;28:289–90.10.1046/j.1537-2995.1988.28388219165.x3368942
Search in Google Scholar Back to article
7 Smith KJ, Coonce LS, South SF, Troup GM. A nti-Cr^a: fem ily study and survival of chromium-labeled incompatible red cells in a Spanish-American patient. Transfusion 1983;23:167–9.10.1046/j.1537-2995.1983.23283172860.x6836696
Search in Google Scholar Back to article
8. Ross DG, McCall L Transfusion significance of anti-Cr^a (letter). Transfusion l985;25:84.10.1046/j.1537-2995.1985.25185116515.x3918364
Search in Google Scholar Back to article
9. International Committee for Standardization in Haematology Recommended method for radioisotope red-cell survival ¾, studies. Br J Hematol 1980;45:659-66.10.1111/j.1365-2141.1980.tb07189.x7426443
Search in Google Scholar Back to article
10. Silvergleid AJ, Wells RF, Hafleigh EB, Korn G, KellnerJJ, Grumet FC. Compatibility testing using ⁵¹chromium labeled red blood cells in crossmatch positive patients. Transfusion 1978;18:8–14.10.1046/j.1537-2995.1978.18178118571.x625785
Search in Google Scholar Back to article
11. Davey RJ, Rosen SL, Gustafson ML, Holland PV ⁵¹ Chromium red cell survival as a measure of transfusion compatibility. Blood 1979;54(supplement 1):121.
Search in Google Scholar Back to article
12. Petz LD, Yam Ę Wilkinson L, Garratty G, Lubin B, Mentzer W Increased IgG molecules bound to the surface of red blood cells Of patients with sickle cell anemia. Blood 1984;64:301–4.10.1182/blood.V64.1.301.301
Search in Google Scholar Back to article
13. Alperin JB, Riglin H, Branch DR, Gallagher MT, Petz LD. Anti-M causing a delayed hemolytic transfusion reaction. Transfusion 1983;23:322–4.10.1046/j.1537-2995.1983.23483276867.x6879672
Search in Google Scholar Back to article
14. Nance SJ, Arndt Ę Garratty G. Predicting the clinical significance of red cell alloantibodies using a monocyte monolayer assay Transfusion 1987;27:449–52.
Search in Google Scholar Back to article

Assessing the clinical significance of anti-Cra and anti-M in a chronically transfused sickle cell patient

References

Paradigm

My account